Follow the Alpha Tau Medical Ltd. share price and the full insider trade history of the company, a listed equity based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Market capitalisation: €1.4bn. The latest transaction was disclosed on 25 August 2026 (Levée d'options). Among the most active insiders: Levy Raphi. All data is free.
24
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€786,180
12 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Alpha Tau Medical Ltd. Buy (bullish), based on 5 analysts. Average price target: US$14.40.
30Σ signal
Buys n/a€786,180 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
15,000 shares@ US$10.757145.8% of flowOrdinary SharesSEC:0001213900-26-065201:1
24 of 24 declarations
About Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd. is a company focused on developing innovative cancer treatments using alpha radiation therapy technology. It is listed on NASDAQ under the ticker ATOU.